Unknown

Dataset Information

0

Cocrystal@protein-anchoring nanococktail for combinatorially treating multidrug-resistant cancer

ABSTRACT:

SUBMITTER: Zou J 

PROVIDER: S-EPMC11544293 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Cost-effectiveness of treating multidrug-resistant tuberculosis.
| S-EPMC1483913 | biostudies-literature
Unknown Repurposing bioactive compounds for treating multidrug-resistant pathogens.
| S-EPMC7363280 | biostudies-literature
Unknown Costs of treating multidrug-resistant TB in California in 2022.
| S-EPMC10599414 | biostudies-literature
Unknown Novel nanococktail of a dual PI3K/mTOR inhibitor and cabazitaxel for castration-resistant prostate cancer.
| S-EPMC7567330 | biostudies-literature
Unknown The Potential of Dutasteride for Treating Multidrug-Resistant Candida auris Infection
| S-EPMC11207579 | biostudies-literature
Unknown Heterotargeted Nanococktail with Traceless Linkers for Eradicating Cancer.
| S-EPMC7546548 | biostudies-literature
Unknown Dual-targeting tigecycline nanoparticles for treating intracranial infections caused by multidrug-resistant Acinetobacter baumannii.
| S-EPMC10981309 | biostudies-literature
Unknown Immunomodulatory Nanozymes Eradicate Intracellular Infections and Rescue Immunoparalysis for Treating Multidrug-Resistant Bacterial Sepsis.
| S-EPMC12561197 | biostudies-literature
Unknown Multidrug-resistant breast cancer: current perspectives.
| S-EPMC3929252 | biostudies-literature
Genomics Multidrug resistant Enterobacteriaceae
| PRJNA286707 | ENA